Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy

Korean Journal of Internal Medicine

Volumn 28, Issue 5, 2013, Pages 573-578

  Maurya, Sanjeev Kumar ^a   Tewari, Mallika ^b   Sharma, Bechan ^c   Shukla, Hari Shanker ^b  

^a Invertis Group of Institutions   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Antiapoptotic molecules; Apoptosis; Gallbladder neoplasms; Signal transduction; Up regulation

Indexed keywords

ANDROGEN RECEPTOR; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROCASPASE 3; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AR PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; WESTERN BLOTTING; CARCINOMA; DRUG EFFECTS; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYMOLOGY; GALLBLADDER NEOPLASMS; NEOPLASMS, HORMONE-DEPENDENT; PATHOLOGY;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CASPASE 3; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84883819646     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2013.28.5.573     Document Type: Article

References (40)

1. Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982;307:798-800.
2. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132-140.
3. Tewari M, Kumar V, Mishra RR, Shukla HS. Gallblad-der carcinoid masquerading as gallbladder carcinoma. Hepatobiliary Pancreat Dis Int 2009;8:326-328.
4. Dhulkotia A, Kumar S, Kabra V, Shukla HS. Aberrant gallbladder situated beneath the left lobe of liver. HPB (Oxford) 2002;4:39-42.
5. Shukla HS, Awasthi K, Naithani YP, Gupta SC. A clini-co-pathological study of carcinoma of the gall bladder. Indian J Cancer 1981;18:198-201.
6. Ohnami S, Nakata H, Nagafuchi Y, Zeze F, Eto S. Es-trogen receptors in human gastric, hepatocellular, and gallbladder carcinomas and normal liver tissues. Gan To Kagaku Ryoho 1988;15:2923-2928.
7. Nakamura S, Muro H, Suzuki S. Estrogen and pro-gesterone receptors in gallbladder cancer. Jpn J Surg 1989;19:189-194.
8. Barreto SG, Haga H, Shukla PJ. Hormones and gall-bladder cancer in women. Indian J Gastroenterol 2009;28:126-130.
9. Egawa N, Tu Y, Kamisawa T. Why is gallbladder cancer more frequent in women than in men? Nihon Rinsho 2006;64 Suppl 1:344-347.
10. Sumi K, Matsuyama S, Kitajima Y, Miyazaki K. Loss of estrogen receptor beta expression at cancer front cor-relates with tumor progression and poor prognosis of gallbladder cancer. Oncol Rep 2004;12:979-984.
11. Ko CY, Schmit P, Cheng L, Thompson JE. Estrogen re-ceptors in gallbladder cancer: detection by an improved immunohistochemical assay. Am Surg 1995;61:930-933.
12. Chen A, Huminer D. The role of estrogen receptors in the development of gallstones and gallbladder cancer. Med Hypotheses 1991;36:259-260.
13. Yamamoto M, Nakajo S, Tahara E. Immunohistochemi-cal analysis of estrogen receptors in human gallbladder. Acta Pathol Jpn 1990;40:14-21.
14. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder can-cer. Gastrointest Cancer Res 2012;5:41-47.
15. Park SK, Andreotti G, Rashid A, et al. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis 2010;31:842-846.
16. Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One 2012;7:e40162.
17. Meyer TE, O'Brien TG, Andreotti G, et al. Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol Biomarkers Prev 2010;19:787-793.
18. Zacks SL, Sandler RS, Rutledge R, Brown RSJr. A pop-ulation-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gas-troenterol 2002;97:334-340.
19. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
20. Johnstone RW, Ruef li AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-164.
21. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchi-cal activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999;144:281-292.
22. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lip-kowitz S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 1999;59:734-741.
23. Bellarosa D, Ciucci A, Bullo A, et al. Apoptotic events in a human ovarian cancer cell line exposed to anthracy-clines. J Pharmacol Exp Ther 2001;296:276-283.
24. Kottke TJ, Blajeski AL, Martins LM, et al. Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis: evidence for EGF-induced anoikis. J Biol Chem 1999;274:15927-15936.
25. Suzuki A, Kawabata T, Kato M. Necessity of interleu-kin-1beta converting enzyme cascade in taxotere-initi-ated death signaling. Eur J Pharmacol 1998;343:87-92.
26. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
27. Cryns V, Yuan J. The cutting edge: caspases in apop-tosis and disease. In: Lockshin RA, Zakeri Z, Tilly JL, eds. When Cells Die: A Comprehensive Evaluation of Apoptosis and Programmed Cell Death. New York: Wi-ley-Liss, 1998:177-210.
28. Maurya SK, Tewari M, Kumar M, Thakur MK, Shukla HS. Expression pattern of tumor endothelial marker 8 protein in gallbladder carcinomas. Asian Pac J Cancer Prev 2011;12:507-512.
29. Horvitz HR, Sternberg PW, Greenwald IS, Fixsen W, Ellis HM. Mutations that affect neural cell lineages and cell fates during the development of the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol 1983;48 Pt 2:453-463.
30. Janicke RU, Ng P, Sprengart ML, Porter AG. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 1998;273:15540-15545.
31. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-in-duced apoptosis. Cancer Res 2001;61:348-354.
32. Kwon KB, Park EK, Ryu DG, Park BH. D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp Mol Med 2002;34:32-37.
33. Henkels KM, Turchi JJ. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 1999;59:3077-3083.
34. Blanc C, Deveraux QL, Krajewski S, et al. Caspase-3 is essential for procaspase-9 processing and cisplatin-in-duced apoptosis of MCF-7 breast cancer cells. Cancer Res 2000;60:4386-4390.
35. Cummings BS, Schnellmann RG. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -indepen-dent pathways. J Pharmacol Exp Ther 2002;302:8-17.
36. Kishimoto S, Kawazoe Y, Ikeno M, Fukushima S, Takeuchi Y. Continuous exposure to low-dose cisplatin and apoptosis. Biol Pharm Bull 2005;28:1954-1957.
37. Wong SC, Chan JK, Lee KC, Hsiao WL. Differential ex-pression of p16/p21/p27 and cyclin D1/D3, and their re-lationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J Pathol 2001;194:35-42.
38. Mommers EC, van Diest PJ, Leonhart AM, Meijer CJ, Baak JP. Balance of cell proliferation and apopto-sis in breast carcinogenesis. Breast Cancer Res Treat 1999;58:163-169.
39. Zhao H, Morimoto T, Sasa M, Tanaka T, Izumi K. Im-munohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. Breast Cancer 2002;9:118-126.
40. Parton M, Krajewski S, Smith I, et al. Coordinate ex-pression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin Cancer Res 2002;8:2100-2108.